Forward Pharma Operations ApS — Credit Rating and Financial Key Figures
CVR number: 38757504
Strandvejen 125, 2900 Hellerup
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 351.02 | 621.56 | 724.02 | 546.95 | 99.13 |
| External services | -8 509.34 | -9 625.97 | -8 619.24 | -2 888.56 | -2 352.72 |
| Gross profit | -8 158.31 | -9 004.41 | -7 895.22 | -2 341.60 | -2 253.59 |
| EBIT | -8 158.31 | -9 004.41 | -7 895.22 | -2 341.60 | -2 253.59 |
| Other financial income | 1 075.35 | 1 235.78 | 960.35 | 3 861.45 | 3 431.90 |
| Other financial expenses | -3 002.94 | -1 706.89 | - 687.94 | - 439.33 | - 239.87 |
| Net income from associates (fin.) | -23.03 | -11.45 | -19 399.61 | -37.31 | -69 258.77 |
| Pre-tax profit | -10 108.94 | -9 486.97 | -27 022.41 | 1 043.21 | -68 320.33 |
| Income taxes | -23.43 | ||||
| Net earnings | -10 108.94 | -9 486.97 | -27 022.41 | 1 043.21 | -68 343.76 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Holdings in group member companies | 19 450.34 | 19 438.89 | 39.28 | ||
| Investments total | 19 450.34 | 19 438.89 | 39.28 | ||
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 95 320.18 | 96 270.99 | 97 231.34 | 277 565.44 | 344 381.32 |
| Prepayments and accrued income | 15.85 | 24.21 | 35.15 | 29.54 | |
| Current other receivables | 356.28 | 742.57 | 1 179.09 | 169.92 | 207.56 |
| Short term receivables total | 95 692.30 | 97 037.77 | 98 445.58 | 277 764.90 | 344 588.88 |
| Cash and bank deposits | 222 016.51 | 210 630.06 | 206 623.93 | 24 348.84 | 4 857.83 |
| Cash and cash equivalents | 222 016.51 | 210 630.06 | 206 623.93 | 24 348.84 | 4 857.83 |
| Balance sheet total (assets) | 337 159.16 | 327 106.72 | 305 108.79 | 302 113.74 | 349 446.71 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Share premium account | 373 034.31 | 373 034.31 | 373 034.31 | ||
| Retained earnings | -48 383.06 | -58 491.99 | -67 978.97 | 278 032.93 | 348 334.90 |
| Profit of the financial year | -10 108.94 | -9 486.97 | -27 022.41 | 1 043.21 | -68 343.76 |
| Shareholders equity total | 314 592.32 | 305 105.35 | 278 082.93 | 279 126.14 | 280 041.15 |
| Non-current liabilities total | |||||
| Current trade creditors | 31.29 | 25.43 | 400.69 | 552.80 | 123.37 |
| Current owed to group member | 22 477.80 | 21 938.01 | 26 625.17 | 22 434.80 | 69 258.77 |
| Short-term deferred tax liabilities | 23.43 | ||||
| Other non-interest bearing current liabilities | 57.75 | 37.94 | |||
| Current liabilities total | 22 566.84 | 22 001.37 | 27 025.85 | 22 987.60 | 69 405.56 |
| Balance sheet total (liabilities) | 337 159.16 | 327 106.72 | 305 108.79 | 302 113.74 | 349 446.71 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.